Fabio
5.6 KiB
5.6 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Pharmaceutical processors; amends the definition of 'cannabis oil.' | Pharmaceutical processors. Amends the definitionof "cannabis oil" by removing the requirement that only oil fromindustrial hemp be used in the formulation of cannabis oil. The billrequires the Board of Pharmacy to publish monthly on its website information including the number of practitioners, patients, registeredagents, and parents or legal guardians of patients in each health service area who have registered with the Board, the number of writtencertifications issued, the number of pending applications for registrations,and the pace at which the Board is approving registrations. The billdirects the Board to promulgate numerous regulations related to pharmaceuticalprocessors. | us/states/va | Virginia General Assembly | 2022 | HB 933 | Virginia HB 933 (2022) |
|
enacted |
|
4 | 29 | 6 | 2022-01-12 | 2022-04-11 | openstates | ocd-bill/1cbf9cdf-5295-474d-98ba-6ec2133bc69b | https://lis.virginia.gov/cgi-bin/legp604.exe?221+sum+HB933 | 1ec102b51df573c1dbe123d16d44c4b631a4217a337937608be1e0204edfb831 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia HB 933 (2022) — Pharmaceutical processors; amends the definition of 'cannabis oil.'
Pharmaceutical processors. Amends the definitionof "cannabis oil" by removing the requirement that only oil fromindustrial hemp be used in the formulation of cannabis oil. The billrequires the Board of Pharmacy to publish monthly on its website information including the number of practitioners, patients, registeredagents, and parents or legal guardians of patients in each health service area who have registered with the Board, the number of writtencertifications issued, the number of pending applications for registrations,and the pace at which the Board is approving registrations. The billdirects the Board to promulgate numerous regulations related to pharmaceuticalprocessors.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0391 (committee substitute) — source
- Committee substitute printed 22106426D-H1 (committee substitute) — source
- HB933ER (committee substitute) — source
- Prefiled and ordered printed; offered 01/12/22 22103788D (committee substitute) — source
Votes
- Subcommittee recommends reporting with substitute (6-Y 0-N) — 6–0 (pass) · lower
- Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
- VOTE: Passage (93-Y 5-N) — 92–5 (pass) · lower
- Reported from Education and Health (15-Y 0-N) — 15–0 (pass) · upper
- Reported from Health, Welfare and Institutions with substitute (19-Y 2-N) — 19–2 (pass) · lower
- Passed Senate (40-Y 0-N) — 40–0 (pass) · upper
Sponsors
- Roxann L. Robinson — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2022-01-12 Prefiled and ordered printed; offered 01/12/22 22103788D
introduction - 2022-01-12 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2022-02-04 Assigned HWI sub: Subcommittee #3
referral-committee - 2022-02-07 Impact statement from DPB (HB933)
- 2022-02-08 House subcommittee amendments and substitutes offered
- 2022-02-08 Subcommittee recommends reporting with substitute (6-Y 0-N)
- 2022-02-10 House committee, floor amendments and substitutes offered
- 2022-02-10 Reported from Health, Welfare and Institutions with substitute (19-Y 2-N)
committee-passage - 2022-02-10 Committee substitute printed 22106426D-H1
substitution - 2022-02-13 Read first time
reading-1 - 2022-02-14 Read second time
reading-2 - 2022-02-14 Committee substitute agreed to 22106426D-H1
- 2022-02-14 Engrossed by House - committee substitute HB933H1
- 2022-02-15 Read third time and passed House (93-Y 5-N)
passage, reading-3 - 2022-02-15 VOTE: Passage (93-Y 5-N)
- 2022-02-15 Impact statement from DPB (HB933H1)
- 2022-02-16 Constitutional reading dispensed
- 2022-02-16 Referred to Committee on Education and Health
referral-committee - 2022-02-24 Reported from Education and Health (15-Y 0-N)
committee-passage - 2022-02-25 Constitutional reading dispensed (39-Y 0-N)
- 2022-02-28 Read third time
reading-3 - 2022-02-28 Passed Senate (40-Y 0-N)
passage - 2022-03-03 Enrolled
- 2022-03-03 Signed by Speaker
- 2022-03-04 Impact statement from DPB (HB933ER)
- 2022-03-04 Signed by President
- 2022-03-11 Enrolled Bill communicated to Governor on March 11, 2022
- 2022-03-11 Governor's Action Deadline 11:59 p.m., April 11, 2022
- 2022-04-11 Approved by Governor-Chapter 391 (effective 7/1/22)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/1cbf9cdf-5295-474d-98ba-6ec2133bc69b. Confidence: reported (aggregated from official Virginia legislature records).